[Controlled clinical study on the efficacy of Phakan as an anticataract drug].
D000328:Adult; D000368:Aged; D000596:Amino Acids / Q000627:therapeutic use*; D001205:Ascorbic Acid / Q000627:therapeutic use*; D002386:Cataract / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004338:Drug Combinations / Q000627:therapeutic use; D006801:Humans; D007294:Inositol / Q000627:therapeutic use*; D008875:Middle Aged; D011736:Pyridoxine / Q000627:therapeutic use*; D011897:Random Allocation
D000596:Amino Acids; D004338:Drug Combinations; D007294:Inositol; C038602:Phakan; D011736:Pyridoxine; D001205:Ascorbic Acid
Kontrollierte klinische Studie über die Wirksamkeit von Phakan als Anti-Kataraktmedikament.